Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2025-12-25 @ 3:24 AM
NCT ID:
NCT00281905
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of 1 of the following:
* Brain stem tumor (histological confirmation not required)
* Histologically confirmed primary intracranial brain tumor of 1 of the following histologies:
* Anaplastic (malignant) astrocytoma
* Glioblastoma
* Anaplastic (malignant) oligodendroglioma
* Ependymoma
* Anaplastic (malignant) ependymoma
* Anaplastic (malignant) oligoastrocytoma
* Choroid plexus carcinoma
* Astroblastoma
* Polar spongioblastoma
* Gliomatosis cerebri
* Anaplastic (malignant) ganglioglioma
* Pineoblastoma
* Mixed pineocytoma or pineoblastoma
* Medulloepithelioma
* Neuroblastoma
* Ependymoblastoma
* Primitive neuroectodermal tumors (PNETs), including medulloblastoma or cerebral or spinal PNETs
* Has undergone surgery or biopsy of the tumor within the past 2-4 weeks
PATIENT CHARACTERISTICS:
* No concurrent unrelated disease, including hematological or renal disease, that would preclude study treatment
PRIOR CONCURRENT THERAPY:
* No prior chemotherapy or radiotherapy
* Prior steroids allowed
* No concurrent steroids as anti-emetics
* Concurrent steroids allowed for control of tumor-related symptoms
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
3 Years
Study:
NCT00281905
Study Brief:
Protocol Section:
NCT00281905